166 related articles for article (PubMed ID: 8085241)
1. Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements.
Leroy-Matheron C; Gouault-Heilmann M
Thromb Res; 1994 May; 74(4):399-407. PubMed ID: 8085241
[TBL] [Abstract][Full Text] [Related]
2. Determination of markers of coagulation activation and reactive fibrinolysis in patients with mechanical heart valve prosthesis at different intensities of oral anticoagulation.
van Wersch JW; van Mourik-Alderliesten CH; Coremans A
Blood Coagul Fibrinolysis; 1992 Apr; 3(2):183-6. PubMed ID: 1606289
[TBL] [Abstract][Full Text] [Related]
3. Influence of anticoagulants used for blood collection on plasma prothrombin fragment F1 + 2 measurements.
Bauer KA; Barzegar S; Rosenberg RD
Thromb Res; 1991 Sep; 63(6):617-28. PubMed ID: 1780806
[TBL] [Abstract][Full Text] [Related]
4. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.
Gando S; Nanzaki S; Sasaki S; Aoi K; Kemmotsu O
Crit Care Med; 1998 Dec; 26(12):2005-9. PubMed ID: 9875912
[TBL] [Abstract][Full Text] [Related]
5. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
6. Relationship between changes in F1+2 and TAT levels and blood coagulation early after prosthetic valve replacement.
Nakamura K; Toyohira H; Kariyazono H; Yamada K; Moriyama Y; Taira A
Thromb Res; 1997 Apr; 86(2):161-71. PubMed ID: 9175237
[TBL] [Abstract][Full Text] [Related]
7. Effects of exercise test on plasma markers of an activation of coagulation and/or fibrinolysis in patients with symptomatic or silent myocardial ischemia.
Bounameaux H; Righetti A; de Moerloose P; Bongard O; Reber G
Thromb Res; 1992 Jan; 65(1):27-32. PubMed ID: 1604440
[TBL] [Abstract][Full Text] [Related]
8. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
9. Blood coagulation parameters in retinal arterial occlusion.
Sagripanti A; Romani A; Ferretti A; Ragone MC; Baicchi U; Carpi A; Nardi M
Graefes Arch Clin Exp Ophthalmol; 1999 Jun; 237(6):480-3. PubMed ID: 10379608
[TBL] [Abstract][Full Text] [Related]
10. D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis.
Boneu B; Bes G; Pelzer H; Sié P; Boccalon H
Thromb Haemost; 1991 Jan; 65(1):28-31. PubMed ID: 2024237
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2.
Greenberg CS; Hursting MJ; Macik BG; Ortel TL; Kane WH; Moore BM
Clin Chem; 1994 Oct; 40(10):1962-9. PubMed ID: 7923780
[TBL] [Abstract][Full Text] [Related]
12. The coagulopathy in acute head injury: comparison of cerebral versus peripheral measurements of haemostatic activation markers.
Murshid WR; Gader AG
Br J Neurosurg; 2002 Aug; 16(4):362-9. PubMed ID: 12389889
[TBL] [Abstract][Full Text] [Related]
13. Markers of coagulation and fibrinolysis in blood drawn into citrate with and without D-Phe-Pro-Arg-Chloromethylketone (PPACK).
Rahr HB; Sørensen JV; Danielsen D
Thromb Res; 1994 Mar; 73(5):279-84. PubMed ID: 8016814
[TBL] [Abstract][Full Text] [Related]
14. Markers of hemostatic system activation in pulmonary embolism. Changes during and after cessation of anticoagulant treatment.
de Raucourt E; Meyer G; Landais P; Gouaref Z; Morinet P; Monge F; Sors H; Fischer AM
Blood Coagul Fibrinolysis; 2000 Apr; 11(3):249-53. PubMed ID: 10870805
[TBL] [Abstract][Full Text] [Related]
15. Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies.
Donohoe S; Quenby S; Mackie I; Panal G; Farquharson R; Malia R; Kingdom J; Machin S
Lupus; 2002; 11(1):11-20. PubMed ID: 11898913
[TBL] [Abstract][Full Text] [Related]
16. Pre-analytical variation in the measurements of sensitive markers of coagulation and fibrinolysis: the influence of venipuncture and mixing of blood.
Iversen LH
Haemostasis; 1997; 27(3):119-24. PubMed ID: 9306128
[TBL] [Abstract][Full Text] [Related]
17. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
[TBL] [Abstract][Full Text] [Related]
18. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic abnormalities may predict chronic hypertension after preeclampsia.
Bremme K; Blombäck M
Gynecol Obstet Invest; 1996; 41(1):20-6. PubMed ID: 8821879
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases.
Chamouard P; Grunebaum L; Wiesel ML; Frey PL; Wittersheim C; Sapin R; Baumann R; Cazenave JP
Eur J Gastroenterol Hepatol; 1995 Dec; 7(12):1183-8. PubMed ID: 8789309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
